OCT Europe: Small and mid-sized sponsors demand smart and reliable partnerships
At the OCT Europe meeting, experts discussed the challenges and strategies of small and mid-sized biopharma companies surrounding clinical trials.
Clinical Trials
First subject enrolled in BioCardia’s Phase III heart failure therapy trial
Design Therapeutics reports positive outcomes from trial of DT-168 eye drops
Tempus selects TIME Network for Phase I clinical trials
Rein Therapeutics to integrate Qureight’s platform in trial of IPF treatment
Neurocrine begins Phase III programme for schizophrenia treatment
Amylyx doses first subject in trial of post-bariatric hypoglycaemia treatment
ProofPilot and DiMe partner to advance development of digital tools for trials
